SCHEDULE 13GAccepted May 15, 6:44 AM ET
Aspire Biopharma Holdings, Inc. SCHEDULE 13G
Accepted (ET)
6:44 AM
May 15, 2026
Filed
May 15, 2026
Documents
1
Size
9.5 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.